22 September 2016 - Lobbyists pushing for medical ­device manufacturers to maintain their lucrative deals on the government’s prostheses list also represent pharmaceutical companies fighting a landmark cost-saving measure proposed for the Pharmaceutical Benefits Scheme.

Health Minister Sussan Ley is understood to have initially proposed price cuts for the list of surgical implants available in the private system, but, amid fierce lobbying from manufacturers, the Turnbull government instead opted for further committee talks.

Read The Australian article